Literature DB >> 33090239

[Cannabinoid hyperemesis as a differential diagnosis of nausea and vomiting in the emergency department].

F Korn1, S Hammerich2, A Gries2.   

Abstract

Cannabinoid hyperemesis syndrome (CHS) is caused by regular cannabis consumption and marked by cyclic episodes of severe emesis, often years after the beginning of cannabis consumption. Classical antiemetic treatment often shows no effect and fatal outcomes have sometimes also been reported. This article describe the case of a young man in whom the diagnosis was made after four presentations due to the typical anamnesis. At this point in time he had already undergone an abdominal computed tomography (CT) and gastroscopy, both with no pathological findings. The symptoms completely receded 6 months after presentation by maintaining cannabis abstinence.

Entities:  

Keywords:  Cannabis abuse; Cyclic vomiting; Drugs; Therapy resistent vomiting; Unclear vomiting

Year:  2021        PMID: 33090239      PMCID: PMC7850992          DOI: 10.1007/s00101-020-00850-2

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  10 in total

1.  Cannabinoid hyperemesis: a case series of 98 patients.

Authors:  Douglas A Simonetto; Amy S Oxentenko; Margot L Herman; Jason H Szostek
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Hair cannabinoid concentrations in emergency patients with cannabis hyperemesis syndrome.

Authors:  Khala Albert; Marco L A Sivilotti; Joey Gareri; Andrew Day; Aaron J Ruberto; Lawrence C Hookey
Journal:  CJEM       Date:  2019-02-26       Impact factor: 2.410

3.  Cyclic vomiting presentations following marijuana liberalization in Colorado.

Authors:  Howard S Kim; John D Anderson; Omeed Saghafi; Kennon J Heard; Andrew A Monte
Journal:  Acad Emerg Med       Date:  2015-04-22       Impact factor: 3.451

4.  Cannabinoid hyperemesis and compulsive bathing: a case series and paradoxical pathophysiological explanation.

Authors:  Dale A Patterson; Emmaleigh Smith; Mark Monahan; Andrew Medvecz; Beth Hagerty; Lisa Krijger; Aakash Chauhan; Mark Walsh
Journal:  J Am Board Fam Med       Date:  2010 Nov-Dec       Impact factor: 2.657

Review 5.  Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Authors:  Cecilia J Sorensen; Kristen DeSanto; Laura Borgelt; Kristina T Phillips; Andrew A Monte
Journal:  J Med Toxicol       Date:  2016-12-20

6.  The Prevalence of Cannabinoid Hyperemesis Syndrome Among Regular Marijuana Smokers in an Urban Public Hospital.

Authors:  Joseph Habboushe; Ada Rubin; Haoming Liu; Robert S Hoffman
Journal:  Basic Clin Pharmacol Toxicol       Date:  2018-02-23       Impact factor: 4.080

7.  Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.

Authors:  Mahra Nourbakhsh; Angela Miller; Jeff Gofton; Graham Jones; Bamidele Adeagbo
Journal:  J Forensic Sci       Date:  2018-05-16       Impact factor: 1.832

8.  Cannabinoid hyperemesis syndrome: a case report and review of pathophysiology.

Authors:  Corina L Iacopetti; Clifford D Packer
Journal:  Clin Med Res       Date:  2014-03-25

9.  Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline.

Authors:  Jeff Lapoint; Seth Meyer; Charles K Yu; Kristi L Koenig; Roneet Lev; Sayone Thihalolipavan; Katherine Staats; Christopher A Kahn
Journal:  West J Emerg Med       Date:  2017-11-08

Review 10.  The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.

Authors:  C Hasenoehrl; U Taschler; M Storr; R Schicho
Journal:  Neurogastroenterol Motil       Date:  2016-08-26       Impact factor: 3.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.